Clinical Professor, Medicine - Infectious Diseases
Clinical Professor, Medicine - Infectious Diseases
Clinical Assistant Professor, Medicine - Infectious Diseases
Lecturer, Medicine - Med/Infectious Diseases
Lecturer, Medicine - Med/Infectious Diseases
Lecturer, Medicine - Med/Infectious Diseases
Lecturer, Medicine - Med/Infectious Diseases
Awards & Accolades
Stanford Health Care is Recognized as a Top Performing Antimicrobial Stewardship Program in California
The California Department of Public Health (CDPH) Healthcare-Associated Infections (HAI) Program has recognized Stanford Health Care as a top performing antimicrobial stewardship programs (ASP) in California. The Stanford Antimicrobial Safety & Sustainability Program has been designated with GOLD status and is now a member of the CDPH Antimicrobial Stewardship Honor Roll.
The goals of the ASP Honor Roll are to promote optimal use of antimicrobials, prevent emergence of antimicrobial resistance and C. difficile infections, and to showcase California healthcare facility ASP that not only follow national guidelines, but also demonstrate outcomes and engage their local healthcare community.
For more information, please visit the California Department of Public Health ASP Honor Roll Website
Stanford Health Care Receives the IDSA Antimicrobial Stewardship Centers of Excellence Designation
Stanford Health Care has been awarded the designation of Antimicrobial Stewardship Centers of Excellence (CoE) by the Infectious Diseases Society of America (IDSA). The CoE program recognizes institutions that have created stewardship programs led by infectious diseases physicians and ID-trained pharmacists that are of the highest quality and have achieved standards aligned with evidence-based national guidelines such as the IDSA-SHEA guidelines and the Centers for Disease Control and Prevention’s Core Elements. Stanford Health Care is one of 194 programs nationwide to have received the designation since the program’s launch in 2017.
The core criteria for the CoE program place emphasis on an institution’s ability to implement stewardship protocols to optimize the treatment of infections and reduce adverse events associated with antibiotic use leveraging electronic health record systems and providing ongoing education to help clinicians improve the quality of patient care and promote patient safety. A panel of esteemed IDSA member leaders evaluate CoE applications against core criteria to make recommendations for the designation. The panel is comprised of five ID-trained physicians and three ID-trained pharmacists with many years of expert stewardship experience.
World Health Organization (WHO) Collaborating Centre for Antimicrobial Resistance and Stewardship
Stanford’s Antimicrobial Safety and Sustainability program (SASS)  has been designated a World Health Organization (WHO) Collaborating Centre for Antimicrobial Resistance and Stewardship. This is the first designation of its kind worldwide for antimicrobial stewardship.
To be designated a WHO collaborating centre, an institution must demonstrate at least 2 years of collaborative work with the WHO. One product of this collaboration has been a free online course that demonstrates how front-line clinicians can incorporate antimicrobial stewardship in their everyday practice. This popular course has enrolled over 20,000 students worldwide in just over 1 year. https://openwho.org/courses/AMR-competencyAntimicrobial resistance has become a global health emergency, comparable to that of climate change in complexity, severity, and the urgency necessary to deal with it. The UN Interagency Coordination Group on Antimicrobial Resistance in consultation with WHO released a report in April 2019 entitled No Time to Wait: Securing the future from drug-resistant infections. One report predicts that antimicrobial resistant infections could cause 10 million deaths globally each year by 2050. As a consequence, the authors of the report demand immediate and coordinated action to avert disaster. A key element of the necessary response is the strict stewardship of antimicrobial use in human medicine, as well as in other domains. Optimizing the use of antimicrobial agents is one of five strategic objectives set out in the WHO global action plan on antimicrobial resistance.
The collaborating centre designation provides a formalized relationship between SASS and WHO.   In this capacity, SASS will continue to support WHO activities aimed at strengthening Member States’ capacity to contain antimicrobial resistance through the implementation of antimicrobial stewardship. This will include developing training and educational material suitable for global use.
Gallery
